No title
Digitalization of the downstream process for monoclonal antibodies can be used as a tool towards more efficient and sustainable processing. One part of digitalization are digital twins, which can help provide insights into a process and be used for process optimization, reducing production costs and accelerating drug discovery. However, creating a useful digital twin is often difficult and time-co
